- Home
- JMSB vs ESPR Comparison
JMSB vs ESPR Comparison
Compare JMSB & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMSB
- ESPR
- Stock Information
- Founded
- JMSB 2005
- ESPR 2008
- Country
- JMSB United States
- ESPR United States
- Employees
- JMSB N/A
- ESPR N/A
- Industry
- JMSB Major Banks
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- JMSB Finance
- ESPR Health Care
- Exchange
- JMSB Nasdaq
- ESPR Nasdaq
- Market Cap
- JMSB 268.9M
- ESPR 305.0M
- IPO Year
- JMSB N/A
- ESPR 2013
- Fundamental
- Price
- JMSB $14.44
- ESPR $0.95
- Analyst Decision
- JMSB
- ESPR Buy
- Analyst Count
- JMSB 0
- ESPR 7
- Target Price
- JMSB N/A
- ESPR $6.07
- AVG Volume (30 Days)
- JMSB 30.2K
- ESPR 5.5M
- Earning Date
- JMSB 04-28-2025
- ESPR 05-06-2025
- Dividend Yield
- JMSB 1.75%
- ESPR N/A
- EPS Growth
- JMSB 233.33
- ESPR N/A
- EPS
- JMSB 1.20
- ESPR N/A
- Revenue
- JMSB $53,688,000.00
- ESPR $332,314,000.00
- Revenue This Year
- JMSB N/A
- ESPR $5.17
- Revenue Next Year
- JMSB N/A
- ESPR N/A
- P/E Ratio
- JMSB $12.03
- ESPR N/A
- Revenue Growth
- JMSB 38.38
- ESPR 185.66
- 52 Week Low
- JMSB $13.81
- ESPR $0.93
- 52 Week High
- JMSB $26.52
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- JMSB 33.48
- ESPR 22.73
- Support Level
- JMSB $13.99
- ESPR $0.93
- Resistance Level
- JMSB $15.46
- ESPR $1.06
- Average True Range (ATR)
- JMSB 0.94
- ESPR 0.09
- MACD
- JMSB -0.07
- ESPR -0.02
- Stochastic Oscillator
- JMSB 18.58
- ESPR 3.57
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc provides banking services. The company offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.